Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell - 9-MTH group results

Feb 10 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to  
                Dec 31, 2021        Dec 31, 2020      Mar 31, 2022 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales             1.49               949 mln            2.11     
                 (+56.8 pct)         (+6.5 pct)       (+63.8 pct)  
  Operating     loss 529 mln        loss 764 mln      loss 377 mln 
  Recurring     loss 351 mln        loss 657 mln      loss 157 mln 
  Net           loss 351 mln        loss 658 mln      loss 157 mln 
  EPS           loss 4.74 yen       loss 9.22 yen    loss 2.20 yen 
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news